Work

Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.2900.2900

Authors: Matthew C. Stubbs, Won-Il Kim, Tina Davis, Jun Qi, James Bradner, Andrew L. Kung, Scott A. Armstrong

Institutions: Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard University, Harvard Stem Cell Institute

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2568243235

FWCI: 0.26

Cites:

Cited by: 3

Related to: 10